Martin Shkreli continues to call sh0ts at disgraced pharmaceutical company from behind bars Prison bars cant stop the Pharma bro. Martin Shkreli, the disgraced pharmaceutical executive serving seven years for jacking up the price of a lifesaving drug for AIDS patients, has continued to wield power at the drug company where the scheme went down, according to a article Thursday. He recently called his handpicked chief executive at Phoenixus AG, Kevin Mulleady, from a contraband smartphone to fire him, the Journal reported. Mulleady, who was on a safari vacation in Africa with his wife, had recently put in for a seven figure pay increase. Shkreli later allegedly agreed to make it a suspension. His other reported barred behavior included phoning in advice to company officials when he could, such as on two offers in 2018 to buy shares from existing shareholders at a steep discount. Yet for his alleged role in the company, Shkreli plans to emerge from prison richer than ever. He could be worth dollar 3.7 billion by the time he is expected to be freed in 2023, according to the Journal. He allegedly plans on acquiring more rare drugs in various stages of development and pumping money into getting them developed to score his big bucks. The FBI reportedly interviewed associates about his role at the drug company. Akeel Mithani, a Phoenixus board member, said Shkreli gets treated like any other shareholder. Shkreli has also had some downtime. Hes reportedly used it tweeting from a new account, which was deleted Tuesday, under the handle @sriole. His targets included Rep. Alexandria Ocasio Cortez and Twitter CEO Jack Dorsey. Here we go with the virtue signaling and white male shaming. @jack walks right into it, apologizing for making billions of dollars, he wrote on Feb. 12, in response to a chain involving Dorsey. Shkreli was sentenced to seven years in prison for defrauding investors back in March 2018. He has served 16 months of his sentence.